| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bio-Rad Laboratories Inc (NYSE: BIO-B)
BIO-B Technical Analysis
3
| As on 31st Mar 2026 BIO-B STOCK Price closed @ 278.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 23.56 & Buy for SHORT-TERM with Stoploss of 99.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BIO-BSTOCK Price
| Open | 278.30 | Change | Price | % |
| High | 278.30 | 1 Day | 28.17 | 11.26 |
| Low | 278.25 | 1 Week | 36.26 | 14.98 |
| Close | 278.25 | 1 Month | -58.82 | -17.45 |
| Volume | 150 | 1 Year | -58.82 | -17.45 |
| 52 Week High 357.65 | 52 Week Low 225.29 | ||||
NYSE USA Most Active Stocks
| FSR | 0.02 | 0.00% |
| DDR | 15.44 | -4.46% |
| TWTR | 53.70 | 0.66% |
| SWN | 7.11 | -0.56% |
| HBI | 6.47 | 0.00% |
| BACA-U | 302.00 | 0.67% |
| ENLC | 14.12 | -0.21% |
| NOK | 8.82 | 6.65% |
| IPG | 24.57 | -1.96% |
| CADE | 42.11 | -1.66% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| BIO-B Daily Charts |
BIO-B Intraday Charts |
Whats New @ Bazaartrend |
BIO-B Free Analysis |
|
|
BIO-B Important Levels Intraday
| RESISTANCE | 278.35 |
| RESISTANCE | 278.32 |
| RESISTANCE | 278.30 |
| RESISTANCE | 278.28 |
| SUPPORT | 278.22 |
| SUPPORT | 278.20 |
| SUPPORT | 278.18 |
| SUPPORT | 278.15 |
BIO-B Forecast April 2026
| 4th UP Forecast | 536.33 |
| 3rd UP Forecast | 453.56 |
| 2nd UP Forecast | 402.4 |
| 1st UP Forecast | 351.24 |
| 1st DOWN Forecast | 205.26 |
| 2nd DOWN Forecast | 154.1 |
| 3rd DOWN Forecast | 102.94 |
| 4th DOWN Forecast | 20.17 |
BIO-B Weekly Forecast
| 4th UP Forecast | 504.15 |
| 3rd UP Forecast | 431.70 |
| 2nd UP Forecast | 386.92 |
| 1st UP Forecast | 342.14 |
| 1st DOWN Forecast | 214.36 |
| 2nd DOWN Forecast | 169.58 |
| 3rd DOWN Forecast | 124.80 |
| 4th DOWN Forecast | 52.35 |
BIO-B Forecast2026
| 4th UP Forecast | 536.33 |
| 3rd UP Forecast | 453.56 |
| 2nd UP Forecast | 402.4 |
| 1st UP Forecast | 351.24 |
| 1st DOWN Forecast | 205.26 |
| 2nd DOWN Forecast | 154.1 |
| 3rd DOWN Forecast | 102.94 |
| 4th DOWN Forecast | 20.17 |
Bio-Rad Laboratories Inc ( NYSE USA Symbol : BIO-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BIO-B Business Profile
Bio-Rad Laboratories, Inc. develops, manufactures, and markets life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Address: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service